logo-loader
viewCentrica PLC

Credit Suisse thinks British Gas owner Centrica will HALVE its dividend next month

Even at 6p a share, Centrica would still be yielding a very high 6.8% based on the current share price of around 88p

british gas
Credit Suisse is ‘neutral’ on Centrica, with a price target of 105p

Analysts at Credit Suisse have warned Centrica Plc (LON:CNA) shareholders to brace themselves for a massive dividend cut in next month’s interim results statement.

The Swiss investment bank had previously expected Centrica to slash its dividend by a third, but they now think the British Gas owner will halve its payouts.

READ: High yields point to 'dividend slaves' that may cut payouts

According to their calculations, the number crunchers believe the divi will fall to around 6p per share, prompting them to trim their price target for the stock.

“Issues surrounding the pensions deficit and delays to asset sales will suppress the dividend in the near-term,” Credit Suisse said in a note to clients.

“We think it is right to focus on dividend yield for valuation purposes, rather than just SOTP [sum of the parts], and this drives the reduction in our target price to 105p/share (from 145p).”

Cash flows under pressure

Given that Centrica currently boasts a whopping 13% dividend yield – anything over 6% usually raises eyebrows in the Square Mile – and costs it almost £700mln every year, Credit Suisse’s view that a cut is inevitable is unlikely to surprise many.

Chief executive Iain Conn said earlier this year that operating cash flow was “under some pressure”, not helped by new limits on household energy bills.

Credit Suisse expects more clarity around the dividend in the half-year results, which are due to be published on 30 July.

Centrica shares were broadly flat at 88.1p on Friday afternoon.

Quick facts: Centrica PLC

Price: 73.56 GBX

LSE:CNA
Market: LSE
Market Cap: £4.28 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Admedus Ltd proud to unveil its valves publicly for the first time in London

Admedus Ltd's (ASX:AHZ) CEO Wayne Paterson caught up with Proactive's Andrew Scott while in London. The firm recently made what's been described as a transformational move to sell off its CardioCel® and VascuCel® patch business. Paterson says the focus is now firmly on the Adapt...

13 hours, 20 minutes ago

RNS

Blocklisting Application

4 days, 18 hours ago

Director/PDMR Shareholding

2 weeks, 2 days ago

Block listing Interim Review

2 weeks, 5 days ago

Total Voting Rights

2 weeks, 5 days ago

Holding(s) in Company

4 weeks, 1 day ago

Total Voting Rights

on 1/10/19

2 min read